J.W. Cole Advisors Inc. Sells 13,077 Shares of SPDR S&P Biotech ETF $XBI

J.W. Cole Advisors Inc. cut its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 55.5% during the fourth quarter, Holdings Channel.com reports. The firm owned 10,503 shares of the exchange traded fund’s stock after selling 13,077 shares during the period. J.W. Cole Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $1,225,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. AQR Capital Management LLC lifted its position in SPDR S&P Biotech ETF by 77.1% during the first quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock valued at $404,000 after acquiring an additional 2,167 shares during the last quarter. Marshall Wace LLP lifted its position in SPDR S&P Biotech ETF by 102.3% during the second quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock valued at $334,000 after acquiring an additional 179,029 shares during the last quarter. The Manufacturers Life Insurance Company purchased a new stake in SPDR S&P Biotech ETF during the second quarter valued at approximately $260,000. Ameriprise Financial Inc. lifted its position in SPDR S&P Biotech ETF by 123.0% during the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock valued at $72,542,000 after acquiring an additional 481,408 shares during the last quarter. Finally, EP Wealth Advisors LLC lifted its position in SPDR S&P Biotech ETF by 3.7% during the second quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock valued at $446,000 after acquiring an additional 193 shares during the last quarter.

SPDR S&P Biotech ETF Stock Up 2.3%

NYSEARCA:XBI opened at $131.38 on Wednesday. SPDR S&P Biotech ETF has a 52 week low of $80.90 and a 52 week high of $139.19. The firm has a 50 day moving average of $132.23 and a 200 day moving average of $126.86. The stock has a market capitalization of $8.38 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.